Canopy Growth (NASDAQ:CGC - Get Free Report) is projected to issue its quarterly earnings data before the market opens on Friday, February 7th. Analysts expect the company to announce earnings of ($0.38) per share and revenue of $69.45 million for the quarter. Investors that are interested in registering for the company's conference call can do so using this link.
Canopy Growth Stock Performance
Shares of NASDAQ CGC traded down $0.02 during midday trading on Monday, hitting $1.97. 6,182,251 shares of the company's stock were exchanged, compared to its average volume of 5,662,022. Canopy Growth has a twelve month low of $1.85 and a twelve month high of $14.92. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.39 and a quick ratio of 1.07. The firm has a market cap of $256.94 million, a P/E ratio of -0.40 and a beta of 0.87. The stock's 50 day moving average price is $2.87 and its 200-day moving average price is $4.43.
Analysts Set New Price Targets
Separately, Atb Cap Markets cut Canopy Growth from a "hold" rating to a "strong sell" rating in a research note on Monday, December 16th.
Read Our Latest Research Report on CGC
Canopy Growth Company Profile
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Further Reading

Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.